bristol-myers

11 ways to play biotech

11 ways to play biotech
The Fast Money traders discuss 11 ways to play biotech.
On a sluggish Monday for U.S. stocks, some biotechnology names shined. Celgene and Agios jumped nearly 3 percent while biotech-linked funds continued their steady climbs from last year.Acquisitions and breakthroughs abound in a sector brimming with options ripe for growth. Traders on CNBC’s “Fast Money” outlined their […]

January 13, 2015 agios, bristol, bristol-myers, celgene, etf, first-trust, squibb, traders Comments Off read more

Best Mutual Funds for Aggressive Investors

istockphotoThree-year annualized return: 28.1%Annual expense ratio: 0.35%Minimum initial investment: $3,000Biggest holdings: Actavis, Merck, Bristol-Myers Squibb, UnitedHealth Group, AstraZenecaVanguard Health Care (VGHCX) is the Grand Pooh-Bah of health care sector funds. Not only is it the biggest, it also charges the least of any health care mutual fund (exchange-traded funds tend to cost less). What’s more, even as Vanguard Health outpaced […]

November 11, 2014 ByHedgeChatter astra, bristol, bristol-myers, health, health-care, hynes, myers, sales, unitedhealth, vanguard-health Comments Off read more